Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-627-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study was conducted by a GLP accredited laboratory using OECD Testing Guideline 471. The study was conducted on Gas oil (polymer-derived), thermal cracked, full range, from which the registered substance is derived via steam stripping, and which is compositionally similar to the registered substance.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- The maximum concentration was 5000 µg/plate (the maximum recommended dose level). Eight concentrations of the test item were assayed in triplicate against each tester strain : 1.5 µg/plate, 5 µg/plate, 15 µg/plate, 50 µg/plate, 150 µg/plate, 500 µg/plate, 1500 µg/plate, and 5000 µg/plate.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: The test item was immiscible in dimethyl sulphoxide at 50 mg/mL but was fully miscible in acetone at 100 mg/mL in solubility checks. Acetone was therefore selected as the vehicle. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- acetone
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48h
- Expression time (cells in growth medium):
- Fixation time (start of exposure up to fixation or harvest of cells):
SELECTION AGENT: histidine (TA98, TA100, TA1535, TA1537) and tryptophan (WP2)
DETERMINATION OF CYTOTOXICITY
- Method: other: scoring of colonies
OTHER:
- Temperature during incubation: 37°C +/- 3°C - Evaluation criteria:
- Method : Scoring of revertant colonies.
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Results for the negative controls (spontaneous mutation rates) were considered to be acceptable.
The test item caused a visible reduction in the growth of the bacterial background lawns of all the test strains, both with and without metabolic activation at 5000 µg/plate. These results were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 µg/plate. A test item precipitate was noted at 5000 µg/plate, but did not prevent the scoring of revertant colonies.
In both Experiments 1 and 2, the test item induced a dose-related, reproductible and statistically significant increase in the frequency of TA98 revertant colonies at and above 15 µg/plate (up to the toxic limit at 5000 µg/plate) in the presence of S9-mix only. At the upper test item dose levels (excluding the maximum dose of 5000 µg/plate) the increases achieved a two-fold increase over the concurrent vehicle controls in both experiments.
Smaller increases were also observed for TA100 at 150 µg/plate in Experiment 1, and at 150 µg/plate and 500 µg/plate in Experiment 2 in the presence of S9-mix only.
There was also a significant increase in TA1535 in the absence of S9-mix at 15, 50 and 150 µg/plate in Experiment 1 only. However, the second experiment did not produce a response at any dose level so, and as a consequence, a third confirmatory experiment was performed to obtain consistent results. The third experiment confirmed the result noted in Experiment 2 with no statistically significant increases observed at any test item dose level. Therefore, the result observed in Experiment 1 was considered spurious because it was non-reproductible and the response were noted at low test item concentrations.
No significant increases in the frequency of revertant colonies were recorded for any of the remaining bacterial strains. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
positive with metabolic activation
The test substance was found to be genotoxic in vitro, in the presence of metabolic activation only. - Executive summary:
The in vitro genotoxicity in bacteria on the substance was determined in accordance with the OECD Guideline for Testing of Chemicals 471. Ames plate incorporation (Experiment 1) and pre-incubation (Experiment 2).
The dose range for Experiment 1 was predetermined and was 1.5 to 5000 µg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was amended following the results of Experiment 1 and was 15 to 5000 μg/plate.
The test item caused a visible reduction in the growth of the bacterial background lawns of all the test strains, both with and without metabolic activation at 5000 µg/plate. These results were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 µg/plate. A test item precipitate was noted at 5000 µg/plate, but did not prevent the scoring of revertant colonies.
In both Experiments 1 and 2, the test item induced a dose-related, reproductible and statistically significant increase in the frequency of TA98 revertant colonies at and above 15 µg/plate (up to the toxic limit at 5000 µg/plate) in the presence of S9-mix only. At the upper test item dose levels (excluding the maximum dose of 5000 µg/plate) the increases achieved a two-fold increase over the concurrent vehicle controls in both experiments.
Smaller increases were also observed for TA100 at 150 µg/plate in Experiment 1, and at 150 µg/plate and 500 µg/plate in Experiment 2 in the presence of S9-mix only.
There was also a significant increase in TA1535 in the absence of S9-mix at 15, 50 and 150 µg/plate in Experiment 1 only. However, the second experiment did not produce a response at any dose level so, and as a consequence, a third confirmatory experiment was performed to obtain consistent results. The third experiment confirmed the result noted in Experiment 2 with no statistically significant increases observed at any test item dose level. Therefore, the result observed in Experiment 1 was considered spurious because it was non-reproductible and the response were noted at low test item concentrations.
No significant increases in the frequency of revertant colonies were recorded for any of the remaining bacterial strains.
It was therefore concluded that the test item was mutagenic with metabolic activation.
Reference
Spontaneous Mutation Rates (Concurrent Negative Controls) | |||||||||
Number of revertants (mean number of colonies per plate) | |||||||||
Base-pair substitution type | Frameshift type | ||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||
Experiment 1 | |||||||||
100 | (100) | 25 | (28) | 15 | (21) | 27 | (30) | 20 | (15) |
98 | 29 | 24 | 36 | 11 | |||||
102 | 29 | 25 | 27 | 15 | |||||
Experiment 2 | |||||||||
80 | (84) | 13 | (13) | 23 | (17) | 16 | (22) | 9 | (9) |
98 | 15 | 8 | 31 | 7 | |||||
75 | 12 | 19 | 19 | 11 | |||||
Experiment 3 | |||||||||
17 | (17) | ||||||||
17 | |||||||||
17 |
Test Results - Experiment 1 - With Metabolic Activation | |||||||||||
Dose level per plate | Number of revertants (mean number of colonies per plate) +/- SD | ||||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||
S9-Mix (+) | Solvent control (acetone) | 68 | (110) 36.1 |
12 | (14) 2.1 |
33 | (35) 4.7 |
25 | (28) 3.1 |
21 | (14) 6.1 |
131 | 16 | 31 | 31 | 9 | |||||||
130 | 13 | 40 | 27 | 13 | |||||||
1.5 µg | 127 | (119) 11.4 |
13 | (12) 1.2 |
16 | (19) 4.6 |
20 | (19) 1.7 |
8 | (12) 6.1 |
|
106 | 11 | 24 | 17 | 19 | |||||||
124 | 11 | 16 | 20 | 9 | |||||||
5 µg | 104 | (111) 13.3 |
13 | (14) 5.0 |
35 | (26) 7.8 |
31 | (31) 4.0 |
15 | (10) 4.4 |
|
102 | 19 | 20 | 35 | 8 | |||||||
126 | 9 | 24 | 27 | 7 | |||||||
15 µg | 136 | (116) 17.4 |
9 | (14) 6.2 |
32 | (28) 6.1 |
27 | (28) 0.6 |
11 | (10) 5.6 |
|
108 | 17 | 31 | 28 | 4 | |||||||
104 | 15 | 21 | 28 | 15 | |||||||
50 µg | 110 | (129) 17.0 |
15 | (17) 2.5 |
31 | (29) 1.5 |
33 | (33) 6.5 |
15 | (18) 2.6 |
|
142 | 17 | 29 | 27 | 20 | |||||||
136 | 20 | 28 | 40 | 19 | |||||||
150 µg | 139 | (146) 6.4 |
13 | (14) 5.6 |
36 | (28) 8.5 |
41 | (39) 2.9 |
9 | (14) 5.0 |
|
150 | 9 | 19 | 36 | 19 | |||||||
150 | 20 | 29 | 41 | 13 | |||||||
500 µg | 140 | (137) 2.6 |
11 | (11) 0.6 |
25 | (27) 1.5 |
60 | (57) 3.5 |
19 | (18) 2.1 |
|
135 | 12 | 27 | 57 | 20 | |||||||
136 | 11 | 28 | 53 | 16 | |||||||
1500 µg | 136 | (133) 5.2 |
11 | (14) 4.2 |
20 | (24) 6.9 |
55 | (57) 2.1 |
13 | (19) 5.1 |
|
136 | 13 | 20 | 59 | 20 | |||||||
127 | 19 | 32 | 58 | 23 | |||||||
5000 µg | 128 | (130) 7.2 |
8 | (8) 4.0 |
36 | (29) 8.3 |
57 | (52) 4.6 |
16 | (15) 2.1 |
|
124 | 4 | 20 | 49 | 17 | |||||||
138 | 12 | 32 | 49 | 13 | |||||||
Positive controls S9-Mix (+) | Name | 2-aminoanthracene | 2-aminoanthracene | 2-aminoanthracene | benzo(a)pyrene | 2-aminoanthracene | |||||
Dose level per plate | 1 µg | 2 µg | 10 µg | 5 µg | 2 µg | ||||||
N° of revertants | 1088 | (1204) 321.7 |
150 | (236) 74.5 |
216 | (192) 21.5 |
111 | (141) 35.4 |
235 | (182) 70.3 |
|
957 | 281 | 174 | 180 | 208 | |||||||
1568 | 277 | 187 | 132 | 102 | |||||||
Test Results - Experiment 1 - Without Metabolic Activation | |||||||||||
Dose level per plate | Number of revertants (mean number of colonies per plate) +/- SD | ||||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||
S9-Mix (-) | Solvent control (acetone) | 114 | (113) 7.0 |
20 | (23) 2.5 |
15 | (17) 6.2 |
17 | (17) 6.5 |
16 | (15) 1.5 |
120 | 25 | 12 | 11 | 13 | |||||||
106 | 23 | 24 | 24 | 15 | |||||||
1.5 µg | 116 | (112) 3.2 |
8 | (20) 10.8 |
32 | (24) 7.0 |
11 | (13) 5.3 |
12 | (11) 4.0 |
|
110 | 23 | 21 | 9 | 7 | |||||||
11 | 29 | 19 | 19 | 15 | |||||||
5 µg | 94 | (106) 10.4 |
23 | (22) 1.7 |
16 | (17) 4.0 |
8 | (13) 54.6 |
13 | (13) 1.5 |
|
112 | 20 | 13 | 16 | 15 | |||||||
112 | 23 | 21 | 16 | 12 | |||||||
15 µg | 100 | (105) 9.0 |
110 | (95) 30.4 |
21 | (27) 8.1 |
19 | (19) 6.0 |
12 | (15) 4.9 |
|
99 | 115 | 36 | 13 | 21 | |||||||
115 | 60 | 23 | 25 | 13 | |||||||
50 µg | 92 | (105) 11.0 |
71 | (56) 17.9 |
25 | (18) 8.7 |
25 | (16) 7.5 |
23 | (20) 3.1 |
|
111 | 60 | 20 | 12 | 21 | |||||||
11 | 36 | 8 | 12 | 17 | |||||||
150 µg | 120 | (112) 24.6 |
41 | (55) 18.5 |
23 | (21) 1.5 |
24 | (22) 4.4 |
16 | (14) 1.7 |
|
84 | 48 | 21 | 17 | 13 | |||||||
131 | 76 | 20 | 25 | 13 | |||||||
500 µg | 118 | (117) 13.0 |
39 | (42) 5.8 |
11 | (21) 10.0 |
24 | (21) 3.5 |
24 | (16) 7.2 |
|
130 | 49 | 31 | 17 | 11 | |||||||
104 | 39 | 20 | 21 | 12 | |||||||
1500 µg | 120 | (115) 5.0 |
40 | (45) 9.0 |
24 | (22) 4.9 |
23 | (20) 6.1 |
13 | (9) 4.0 |
|
110 | 39 | 25 | 13 | 9 | |||||||
114 | 55 | 16 | 24 | 5 | |||||||
5000 µg | 100 | (109) 9.0 |
17 | (24) 7.5 |
25 | (21) 5.3 |
8 | (13) 5.6 |
13 | (8) 4.6 |
|
110 | 32 | 23 | 19 | 4 | |||||||
118 | 23 | 15 | 12 | 7 | |||||||
Positive controls S9-Mix (-) | Name | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | 4-nitroquinoline-N-oxide | 9-aminoacridine | |||||
Dose level per plate | 3 µg | 5 µg | 2 µg | 0.2 µg | 80 µg | ||||||
N° of revertants | 524 | (565) 121.8 |
512 | (828) 282.8 |
524 | (462) 90.0 |
269 | (295) 36.7 |
559 | (519) 99.6 |
|
469 | 1058 | 504 | 337 | 406 | |||||||
702 | 913 | 359 | 279 | 593 | |||||||
Test Results - Experiment 2 - With Metabolic Activation | |||||||||||
Dose level per plate | Number of revertants (mean number of colonies per plate) +/- SD | ||||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||
S9-Mix (+) | Solvent control (acetone) | 116 | (91) 22.9 |
9 | (11) 1.5 |
20 | (22) 4.0 |
15 | (18) 8.5 |
(8) 3.0 |
|
71 | 12 | 27 | 12 | ||||||||
86 | 11 | 20 | 28 | ||||||||
1.5 µg | 115 | (113) 4.0 |
9 | (8) 0.6 |
13 | (19) 6.0 |
17 | (20) 3.1 |
(5) 2.6 |
||
115 | 8 | 25 | 19 | ||||||||
108 | 8 | 19 | 23 | ||||||||
5 µg | 108 | (109) 2.1 |
9 | (9) 0.6 |
20 | (20) 0.6 |
19 | (20) 4.6 |
(6) 1.2 |
||
111 | 9 | 20 | 25 | ||||||||
107 | 8 | 19 | 16 | ||||||||
15 µg | 104 | (113) 8.3 |
9 | (9) 0.6 |
32 | (25) 6.5 |
29 | (25) 3.2 |
(5) 1.5 |
||
120 | 8 | 19 | 24 | ||||||||
116 | 9 | 25 | 23 | ||||||||
50 µg | 96 | (105) 8.2 |
11 | (12) 4.2 |
24 | (22) 4.0 |
40 | (38) 7.8 |
(5) 1.5 |
||
107 | 9 | 17 | 29 | ||||||||
112 | 17 | 24 | 44 | ||||||||
150 µg | 120 | (126) 5.1 |
8 | (10) 4.0 |
27 | (27) 0.0 |
60 | (48) 10.6 |
(7) 2.1 |
||
130 | 8 | 27 | 44 | ||||||||
127 | 15 | 27 | 40 | ||||||||
500 µg | 121 | (120) 1.2 |
13 | (11) 2.5 |
27 | (24) 8.3 |
59 | (57) 4.9 |
8 | (10) 4.0 |
|
119 | 8 | 15 | 51 | 8 | |||||||
121 | 11 | 31 | 60 | 15 | |||||||
1500 µg | 88 | (91) 16.2 |
5 | (7) 2.1 |
20 | (25) 6.8 |
52 | (52) 0.6 |
19 | (16) 3.1 |
|
108 | 9 | 33 | 52 | 15 | |||||||
76 | 8 | 23 | 53 | 13 | |||||||
5000 µg | 68 | (93) 22.0 |
8 | (17) 1.7 |
31 | (30) 5.0 |
55 | (64) 8.5 |
15 | (11) 3.8 |
|
104 | 5 | 25 | 72 | 8 | |||||||
108 | 8 | 35 | 65 | 9 | |||||||
Positive controls S9-Mix (+) | Name | 2-aminoanthracene | 2-aminoanthracene | 2-aminoanthracene | benzo(a)pyrene | 2-aminoanthracene | |||||
Dose level per plate | 1 µg | 2 µg | 10 µg | 5 µg | 2 µg | ||||||
N° of revertants | 1637 | (155_) 131.9 |
230 | (230) 18.5 |
164 | (179) 12.7 |
222 | (222) 15.0 |
289 | (299) 8.7 |
|
1406 | 212 | 186 | 237 | 303 | |||||||
1632 | 249 | 186 | 207 | 305 | |||||||
Test Results - Experiment 2 - Without Metabolic Activation | |||||||||||
Dose level per plate | Number of revertants (mean number of colonies per plate) +/- SD | ||||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||
S9-Mix (-) | Solvent control (acetone) | 86 | (85) 4.2 |
12 | (14) 4.0 |
27 | (19) 7.2 |
12 | (14) 2.1 |
7 | (8) 2.3 |
88 | 12 | 17 | 13 | 7 | |||||||
80 | 19 | 13 | 16 | 11 | |||||||
1.5 µg | 75 | (72) 3.0 |
19 | (12) 5.8 |
13 | (15) 2.1 |
9 | (11) 1.5 |
5 | (5) 0.0 |
|
72 | 9 | 16 | 11 | 5 | |||||||
69 | 9 | 17 | 12 | 5 | |||||||
5 µg | 74 | (86) 11.1 |
11 | (12) 1.2 |
16 | (17) 2.3 |
11 | (14) 3.1 |
3 | (7) 4.0 |
|
96 | 13 | 16 | 15 | 11 | |||||||
88 | 11 | 20 | 17 | 7 | |||||||
15 µg | 86 | (87) 5.0 |
8 | (8) 0.0 |
20 | (16) 4.0 |
11 | (13) 3.2 |
9 | (6) 3.1 |
|
92 | 8 | 16 | 17 | 5 | |||||||
82 | 8 | 12 | 12 | 3 | |||||||
50 µg | 69 | (71) 4.4 |
11 | (14) 4.6 |
21 | (20) 2.3 |
12 | (17) 8.7 |
7 | (8) 3.1 |
|
68 | 11 | 21 | 12 | 5 | |||||||
76 | 19 | 17 | 27 | 11 | |||||||
150 µg | 96 | (82) 12.5 |
15 | (15) 5.5 |
17 | (22) 4.4 |
20 | (19) 1.7 |
8 | (6) 1.7 |
|
72 | 20 | 25 | 20 | 5 | |||||||
78 | 9 | 24 | 17 | 5 | |||||||
500 µg | 78 | (75) 2.6 |
12 | (12) 0.0 |
17 | (20) 3.1 |
9 | (12) 3.1 |
5 | (5) 1.5 |
|
73 | 12 | 19 | 11 | 4 | |||||||
74 | 12 | 23 | 15 | 7 | |||||||
1500 µg | 78 | (69) 7.6 |
12 | (12) 0.6 |
17 | (17) 0.0 |
8 | (11) 3.8 |
5 | (4) 1.0 |
|
66 | 12 | 17 | 15 | 4 | |||||||
64 | 11 | 17 | 9 | 3 | |||||||
5000 µg | 63 | (68) 4.6 |
8 | (8) 0.6 |
19 | (20) 0.1 |
17 | (13) 4.0 |
1 | (4) 2.3 |
|
71 | 9 | 20 | 13 | 5 | |||||||
71 | 8 | 21 | 9 | 5 | |||||||
Positive controls S9-Mix (-) | Name | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | 4-nitroquinoline-N-oxide | 9-aminoacridine | |||||
Dose level per plate | 3 µg | 5 µg | 2 µg | 0.2 µg | 80 µg | ||||||
N° of revertants | 480 | (459) 64.7 |
175 | (161) 45.6 |
441 | (440) 18.0 |
227 | (234) 5.8 |
482 | (688) 255.7 |
|
386 | 198 | 457 | 237 | 607 | |||||||
510 | 110 | 421 | 237 | 974 | |||||||
Test Results - Experiment 3 - Without Metabolic Activation | |||||||||||
Dose level per plate | Number of revertants (mean number of colonies per plate) +/- SD | ||||||||||
Base-pair substitution type | Frameshift type | ||||||||||
TA100 | TA1535 | WP2uvrA | TA98 | TA1537 | |||||||
S9-Mix (-) | Solvent control (acetone) | 21 | (16) 4.2 |
||||||||
13 | |||||||||||
15 | |||||||||||
1.5 µg | 23 | (18) 4.2 |
|||||||||
17 | |||||||||||
15 | |||||||||||
5 µg | 17 | (12) 4.6 |
|||||||||
9 | |||||||||||
9 | |||||||||||
15 µg | 17 | (15) 2.5 |
|||||||||
12 | |||||||||||
15 | |||||||||||
50 µg | 9 | (14) 4.2 |
|||||||||
17 | |||||||||||
15 | |||||||||||
150 µg | 8 | (16) 6.9 |
|||||||||
20 | |||||||||||
20 | |||||||||||
500 µg | 28 | (16) 11.4 |
|||||||||
7 | |||||||||||
13 | |||||||||||
1500 µg | 9 | (10) 5.0 |
|||||||||
5 | |||||||||||
15 | |||||||||||
5000 µg | 8 | (13) 6.2 |
|||||||||
20 | |||||||||||
11 | |||||||||||
Positive controls S9-Mix (-) | Name | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | N-ethyl-N-nitro-N-nitrosoguanidine | 4-nitroquinoline-N-oxide | 9-aminoacridine | |||||
Dose level per plate | 3 µg | 5 µg | 2 µg | 0.2 µg | 80 µg | ||||||
N° of revertants | 191 | (173) 16.6 |
|||||||||
171 | |||||||||||
158 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Additional information
The in vitro genotoxicity in bacteria on the read-across substance Gas oil (polymer derived) thermal-cracked, full range was determined in accordance with the OECD Guideline for Testing of Chemicals 471. Ames plate incorporation (Experiment 1) and pre-incubation (Experiment 2).
The dose range for Experiment 1 was predetermined and was 1.5 to 5000 µg/plate. The experiment was repeated on a separate day (pre-incubation method) using fresh cultures of the bacterial strains and fresh test item formulations. The dose range was amended following the results of Experiment 1 and was 15 to 5000 μg/plate.
The test item caused a visible reduction in the growth of the bacterial background lawns of all the test strains, both with and without metabolic activation at 5000 µg/plate. These results were not indicative of toxicity sufficiently severe enough to prevent the test item being tested up to the maximum recommended dose level of 5000 µg/plate. A test item precipitate was noted at 5000 µg/plate, but did not prevent the scoring of revertant colonies.
In both Experiments 1 and 2, the test item induced a dose-related, reproductible and statistically significant increase in the frequency of TA98 revertant colonies at and above 15 µg/plate (up to the toxic limit at 5000 µg/plate) in the presence of S9-mix only. At the upper test item dose levels (excluding the maximum dose of 5000 µg/plate) the increases achieved a two-fold increase over the concurrent vehicle controls in both experiments.
Smaller increases were also observed for TA100 at 150 µg/plate in Experiment 1, and at 150 µg/plate and 500 µg/plate in Experiment 2 in the presence of S9-mix only.
There was also a significant increase in TA1535 in the absence of S9-mix at 15, 50 and 150 µg/plate in Experiment 1 only. However, the second experiment did not produce a response at any dose level so, and as a consequence, a third confirmatory experiment was performed to obtain consistent results. The third experiment confirmed the result noted in Experiment 2 with no statistically significant increases observed at any test item dose level. Therefore, the result observed in Experiment 1 was considered spurious because it was non-reproductible and the response were noted at low test item concentrations.
No significant increases in the frequency of revertant colonies were recorded for any of the remaining bacterial strains.
It was therefore concluded that the result was positive with metabolic activation.
The in vitro genotoxicity in bacteria of the read-across substance Distillates (petroleum), light catalytic cracked was determined by a GLP accredited laboratory using a method similar to OECD 476.
In the mouse lymphoma forward mutation assay, in vitro treatments of the mouse lymphoma cell line L5178Y, with the test substance induced significant increases in the mutation frequency at the thymidine kinase (TK) locus only in the presence of metabolic activation. The cells were exposed to the test substance for four hours in the presence and absence of rat liver S9 metabolic activation and the test material was soluble up to 50nl/ml. Under nonactivation conditions, the test substance was assayed at an applied concentration range of 5nl/ml to 60nl/ml without inducing significant increases in the mutant frequency. Non detectable to moderate toxicities were induced and a small increase in concentration from 60nl/ml to 80nl/ml was excessively toxic and the treatment could not be cloned. In the presence of the metabolic activation mix, the test substance was assayed from 2.5 nl/ml to 25 nl/ml and significant dose-dependant increases in the mutant frequency were induced above 5.0nl/ml where low to very high toxicities were induced.
It was therefore concluded that the result was positive with metabolic activation.
The in vivo cytogenicity of the read-across substance Distillates (petroleum), light catalytic cracked was determined according to a method similar to the OECD Guideline for Testing of chemicals 475. Chromosome aberrations were evaluated in Sprague-Dawley rats after administration by intraperitoneal route.
The results were negative for acute cytogenotoxicity. The animals were exposed to 0.2, 0.67, or 2g/kg of the test item using corn oil as a vehicle for 6, 24 and 48 hours before the rat was sacrificed and the bone marrow removed. The incidence of cells with aberrations was not significantly increased when compared to the vehicle control. Triethylenemelamine was used as a positive control. Rats showed signs of lethargic behaviour, scruffy coat, blood around nose, disorientation and uncoordination, and death on a dose and time related correlation.
The test item was therefore evaluated as none genotoxic under the conditions of this assay.
Evaluation of genetic toxicity is addressing two different mechanisms: gene mutation and action on chromosomes (aneugenicity and clastogenicity). The in vitro gene mutation assay in bacteria is used as a screening test as it is a well-known method able to identify a large amount of genotoxic substances; however, as it is performed on bacteria, it can identify issues that would not happen in mammalian cells, justifying the need to perform further testing.
The two in vitro assays in mammalian cells required in Annex VIII of REACH are designed in order to assess respectively the potential of the substance to induce gene mutation and to affect chromosomes. Depending on the outcome of these in vitro assays on mammalian cells, in vivo assays can be proposed to fully investigate the issues previously identified. Therefore, the in vivo studies must be selected depending on these results.
For the registered substance, read-across substances considered as representing worse-case scenarios for genetic toxicity were selected. Regarding the potential to affect chromosomes, only in vivo studies were available, which came back as negative. Regarding the potential to induce gene mutation, only in vitro studies were available, which came back as negative without metabolic activation and positive with metabolic activation. From these results, the registered substance is not considered as affecting chromosomes, but it can be expected as inducing gene mutation, which could be confirmed by an in vivo study selected to address this particular mechanism, in accordance with Annex VIII of REACH. However, it is not considered as necessary to perform an additional animal study as it has been decided to classify the registered substance as Mut 1B based on these positive in vitro results.
Justification for selection of genetic toxicity endpoint
Study was conducted by a GLP accredited laboratory using OECD Testing Guideline 471. The study was conducted on Gas oil (polymer-derived), thermal cracked, full range, from which the registered substance is derived via steam stripping, and which is compositionally similar to the registered substance.
Justification for classification or non-classification
As the in vivo cytogenicity study on a read-across substance provided a negative result under the conditions of the test, in accordance with the Regulation (EC) No.1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures, the registered substance does not meet the criteria for classification as mutagenic.
However, the positive results obtained on read-across substances during the in vitro gene mutation studies, in bacteria and mammalian, are suggesting that the genotoxicity of the registered substance would be associated with a gene mutation activity. The in vivo cytogenicity study is not considered as sufficient to assess if the registered substance does display a gene mutation activity in vivo. Therefore, it is proposed a classification of the registered substance as Mut 1B, in order to provide a conservative approach.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.